501 related articles for article (PubMed ID: 15537349)
1. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.
Bolognesi ML; Bartolini M; Cavalli A; Andrisano V; Rosini M; Minarini A; Melchiorre C
J Med Chem; 2004 Nov; 47(24):5945-52. PubMed ID: 15537349
[TBL] [Abstract][Full Text] [Related]
2. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
5. Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
Camps P; Formosa X; Galdeano C; Gómez T; Muñoz-Torrero D; Scarpellini M; Viayna E; Badia A; Clos MV; Camins A; Pallàs M; Bartolini M; Mancini F; Andrisano V; Estelrich J; Lizondo M; Bidon-Chanal A; Luque FJ
J Med Chem; 2008 Jun; 51(12):3588-98. PubMed ID: 18517184
[TBL] [Abstract][Full Text] [Related]
6. Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation.
Xie Q; Wang H; Xia Z; Lu M; Zhang W; Wang X; Fu W; Tang Y; Sheng W; Li W; Zhou W; Zhu X; Qiu Z; Chen H
J Med Chem; 2008 Apr; 51(7):2027-36. PubMed ID: 18333606
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.
Rampa A; Bisi A; Valenti P; Recanatini M; Cavalli A; Andrisano V; Cavrini V; Fin L; Buriani A; Giusti P
J Med Chem; 1998 Oct; 41(21):3976-86. PubMed ID: 9767635
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease.
Muñoz-Ruiz P; Rubio L; García-Palomero E; Dorronsoro I; del Monte-Millán M; Valenzuela R; Usán P; de Austria C; Bartolini M; Andrisano V; Bidon-Chanal A; Orozco M; Luque FJ; Medina M; Martínez A
J Med Chem; 2005 Nov; 48(23):7223-33. PubMed ID: 16279781
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 3. Effect of replacing the inner polymethylene chain with cyclic moieties.
Tumiatti V; Andrisano V; Banzi R; Bartolini M; Minarini A; Rosini M; Melchiorre C
J Med Chem; 2004 Dec; 47(26):6490-8. PubMed ID: 15588084
[TBL] [Abstract][Full Text] [Related]
11. Benzophenone-based derivatives: a novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
Belluti F; Bartolini M; Bottegoni G; Bisi A; Cavalli A; Andrisano V; Rampa A
Eur J Med Chem; 2011 May; 46(5):1682-93. PubMed ID: 21397996
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of coumarin derivatives tethered to an edrophonium-like fragment as highly potent and selective dual binding site acetylcholinesterase inhibitors.
Pisani L; Catto M; Giangreco I; Leonetti F; Nicolotti O; Stefanachi A; Cellamare S; Carotti A
ChemMedChem; 2010 Sep; 5(9):1616-30. PubMed ID: 20677317
[TBL] [Abstract][Full Text] [Related]
13. Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine.
Luo W; Yu QS; Zhan M; Parrish D; Deschamps JR; Kulkarni SS; Holloway HW; Alley GM; Lahiri DK; Brossi A; Greig NH
J Med Chem; 2005 Feb; 48(4):986-94. PubMed ID: 15715468
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
Pan L; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS
Bioorg Med Chem Lett; 2008 Jul; 18(13):3790-3. PubMed ID: 18524585
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors.
Huang L; Shi A; He F; Li X
Bioorg Med Chem; 2010 Feb; 18(3):1244-51. PubMed ID: 20056426
[TBL] [Abstract][Full Text] [Related]
16. 3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy.
Piazzi L; Rampa A; Bisi A; Gobbi S; Belluti F; Cavalli A; Bartolini M; Andrisano V; Valenti P; Recanatini M
J Med Chem; 2003 Jun; 46(12):2279-82. PubMed ID: 12773032
[TBL] [Abstract][Full Text] [Related]
17. Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives.
Piazzi L; Cavalli A; Belluti F; Bisi A; Gobbi S; Rizzo S; Bartolini M; Andrisano V; Recanatini M; Rampa A
J Med Chem; 2007 Aug; 50(17):4250-4. PubMed ID: 17655212
[TBL] [Abstract][Full Text] [Related]
18. The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamates.
Groner E; Ashani Y; Schorer-Apelbaum D; Sterling J; Herzig Y; Weinstock M
Mol Pharmacol; 2007 Jun; 71(6):1610-7. PubMed ID: 17347320
[TBL] [Abstract][Full Text] [Related]
19. Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Brunhofer G; Fallarero A; Karlsson D; Batista-Gonzalez A; Shinde P; Gopi Mohan C; Vuorela P
Bioorg Med Chem; 2012 Nov; 20(22):6669-79. PubMed ID: 23062825
[TBL] [Abstract][Full Text] [Related]
20. 4-Aryl-4-oxo-N-phenyl-2-aminylbutyramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields.
Vitorović-Todorović MD; Juranić IO; Mandić LM; Drakulić BJ
Bioorg Med Chem; 2010 Feb; 18(3):1181-93. PubMed ID: 20061157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]